» Articles » PMID: 38699133

Atypical Normokalemic Case of Thyrotoxic Periodic Paralysis in a Pediatric Patient

Overview
Journal Cureus
Date 2024 May 3
PMID 38699133
Authors
Affiliations
Soon will be listed here.
Abstract

Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism characterized by typical muscular symptoms, ranging from paresis to complete paralysis, commonly associated with low potassium blood levels (<3 mmol/l). It is more commonly reported in adult Asian individuals and can lead to life-threatening situations. Therefore, early clinical diagnosis and targeted therapy are of crucial importance. In this article, we report the case of a 17-year-old adolescent with a Vietnamese background and known Graves' disease who was admitted with typical TPP-related symptoms but no hypokalemia. After treatment with an antithyroid medication and oral potassium supplementation, no new episode of TPP was observed. Using next-generation sequencing, a genetic analysis of TPP-related ion channel genes (KCNJ2, KCNJ18, KCNE3, SCN4A, and CACNA1S) found no known/likely pathogenic variants or variants of unknown significance. To the best of our knowledge, this is only the second reported case of quite normokalemic TPP in the pediatric population. Prompt diagnosis of TPP is essential to prevent harmful complications. Supplementation with potassium appears to be successful alongside non-selective beta-blockers. Normalization of thyroid function should be pursued to prevent new attacks, which is considered the best preventive measure.

Citing Articles

Thyrotoxic Periodic Paralysis With Graves' Disease: A Case Report.

Thomas A, Baby B, Joy S, T P S, K P G Cureus. 2024; 16(11):e73223.

PMID: 39650991 PMC: 11624895. DOI: 10.7759/cureus.73223.

References
1.
Al-Zubeidi H, Demeterco C, Jones K . Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents. J Pediatr Endocrinol Metab. 2014; 28(1-2):157-61. DOI: 10.1515/jpem-2014-0016. View

2.
Ryan D, Dias da Silva M, Soong T, Fontaine B, Donaldson M, Kung A . Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell. 2010; 140(1):88-98. PMC: 2885139. DOI: 10.1016/j.cell.2009.12.024. View

3.
Imashuku S, Teramura-Ikeda T, Kudo N, Kaneda S, Tajima T . Concurrence of thyrotoxicosis and Gitelman's syndrome-associated hypokalemia-induced periodic paralysis. Pediatr Rep. 2012; 4(2):e18. PMC: 3395976. DOI: 10.4081/pr.2012.e18. View

4.
Song I, Sung C, Chen C, Cheng C, Yang S, Chou Y . Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis. Neurology. 2016; 86(13):1190-8. DOI: 10.1212/WNL.0000000000002524. View

5.
Garla V, Gunturu M, Kovvuru K, Salim S . Thyrotoxic periodic paralysis: case report and review of the literature. Electron Physician. 2018; 10(8):7174-7179. PMC: 6122872. DOI: 10.19082/7174. View